Sjogren’s Syndrome with Rheumatoid Arthritis
What is Rheumatoid Arthritis?
Rheumatoid arthritis (RA) is an autoimmune disease that affects the joints. The symptoms of rheumatoid arthritis include joint pain, swelling, fatigue, weakness, and stiffness (stiffness especially in the morning), and they can lead to loss of joint function and permanent joint damage. Early treatment for rheumatoid arthritis can help manage symptoms, improve joint function, and help stop progressive joint damage.
Tests for rheumatoid arthritis include positive rheumatoid factor (RF), ANA, sedimentation rate, and C-reactive protein tests in the blood. These tests can show abnormal results due to RA or due other systemic autoimmune and inflammatory conditions. Therefore, abnormalities in these blood tests alone are not sufficient for a firm diagnosis of rheumatoid arthritis.
Rheumatoid Arthritis and Sjogren’s Syndrome – “Secondary Sjogren’s”
When people with Sjogren’s syndrome also have rheumatoid arthritis, it is called Secondary Sjogren’s.
Sjogren’s syndrome is classified as either primary or secondary. Primary Sjogren’s syndrome is diagnosed when the disease occurs in the absence of another underlying rheumatic disorder.The secondary form is diagnosed in people who already have another autoimmune disease such as systemic lupus erythmatosus (Lupus) or rheumatoid arthritis (RA). Statistically, Sjogren’s syndrome cases are fairly equally divided between the primary and secondary forms.
Given the overlap of Sjogren’s syndrome with many other autoimmune disorders, it is sometimes difficult to determine whether a clinical manifestation is solely a consequence of Sjogren’s syndrome or is due to one of its overlapping disorders.
Primary Sjogren’s syndrome moves more quickly and causes decreased function in the lacrimal (for the eyes) and salivary glands (for the mouth). Secondary Sjogren’s syndrome generally causes less severe dryness in the mouth and eyes; however, patients must manage both the effects of their primary disease and the effects of their secondary Sjogren’s.
Primary Sjogren’s Syndrome Diagnosis
The diagnosis of primary Sjogren’s syndrome is based on the following factors, including:
- Presence of dry eyes and mouth. An eye specialist can detect dry eyes by measuring tear volume and looking at the cornea of the eye.
- Laboratory tests indicating dry eyes and mouth are caused by autoimmune mechanisms include positive auto-antibodies in the blood, known as anti-SSA or anti-SSB (also called anti-Ro or anti-La).
- Biopsy of the inner lip (performed in some cases to prove the diagnosis of primary Sjogren’s syndrome). The biopsy may show inflammation that is damaging salivary glands.
Secondary Sjogren’s Syndrome Diagnosis
Secondary Sjogren’s syndrome is generally diagnosed when someone with an established autoimmune disease, such as rheumatoid arthritis or lupus, develops extreme dryness of the eyes and mouth. This diagnosis only rarely requires a lip biopsy.
Powerful All Natural Oral Treatment for Sjogren’s Dry Eyes, Joint Pain.
References
- 1.Holdgate Nicholas, St.Clair E. Wiliam. Recent advances in primary Sjogren’s syndrome. F1000Research. 2016;5:1412. doi: 10.12688/f1000research.8352.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Patel R, Shahane A. The epidemiology of Sjogren’s syndrome. Clin Epidemiol. 2014;6:247–255. doi: 10.2147/CLEP.S47399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Mavragani CP, Moutsopoulos HM. Primary versus secondary Sjogren syndrome: is it time to reconsider these terms? J Rheumatol. 2019;46:665–666. doi: 10.3899/jrheum.180392. [DOI] [PubMed] [Google Scholar]
- 4.He J, Ding Y, Feng M, Guo J, Sun X, Zhao J, Yu D, Li Z. Characteristics of Sjogren’s syndrome in rheumatoid arthritis. Rheumatology (Oxford) 2013;52:1084–1089. doi: 10.1093/rheumatology/kes374. [DOI] [PubMed] [Google Scholar]
- 5.Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD, Merkel PA, Pillemer SR, Reveille JD, Stone JH, National Arthritis Data W Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008;58:15–25. doi: 10.1002/art.23177. [DOI] [PubMed] [Google Scholar]
- 6.Simon TA, Kawabata H, Ray N, Baheti A, Suissa S, Esdaile JM. Prevalence of co-existing autoimmune disease in rheumatoid arthritis: a cross-sectional study. Adv Ther. 2017;34:2481–2490. doi: 10.1007/s12325-017-0627-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Alani H, Henty JR, Thompson NL, Jury E, Ciurtin C. Systematic review and meta-analysis of the epidemiology of polyautoimmunity in Sjogren’s syndrome (secondary Sjogren’s syndrome) focusing on autoimmune rheumatic diseases. Scand J Rheumatol. 2018;47:141–154. doi: 10.1080/03009742.2017.1324909. [DOI] [PubMed] [Google Scholar]
- 8.Brown LE, Frits ML, Iannaccone CK, Weinblatt ME, Shadick NA, Liao KP. Clinical characteristics of RA patients with secondary SS and association with joint damage. Rheumatology (Oxford) 2015;54:816–820. doi: 10.1093/rheumatology/keu400. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Carmona L, Gonzalez-Alvaro I, Balsa A, Angel Belmonte M, Tena X, Sanmarti R. Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity. Ann Rheum Dis. 2003;62:897–900. doi: 10.1136/ard.62.9.897. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Andonopoulos AP, Drosos AA, Skopouli FN, Acritidis NC, Moutsopoulos HM. Secondary Sjogren’s syndrome in rheumatoid arthritis. J Rheumatol. 1987;14:1098–1103. [PubMed] [Google Scholar]
- 11.Uhlig T, Kvien TK, Jensen JL, Axell T. Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis. Ann Rheum Dis. 1999;58:415–422. doi: 10.1136/ard.58.7.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Mertzanis P, Abetz L, Rajagopalan K, Espindle D, Chalmers R, Snyder C, Caffery B, Edrington T, Simpson T, Nelson JD, Begley C. The relative burden of dry eye in patients’ lives: comparisons to a U.S. normative sample. Invest Ophthalmol Vis Sci. 2005;46:46–50. doi: 10.1167/iovs.03-0915. [DOI] [PubMed] [Google Scholar]
- 13.Alemao E, Saini Y, Bao Y, Rao A, Iannaccone CK, Weinblatt ME, Shadick N (2018) The joint disease burden in patients with secondary Sjögren’s syndrome and RA compared to patients with RA only [abstract]. Arthritis Rheum 70(suppl 10):abstract 2506
- 14.Crilly MA, Johnston MC, Black C. Relationship of EQ-5D quality of life with the presence of co-morbidity and extra-articular features in patients with rheumatoid arthritis. Qual Life Res. 2014;23:1435–1443. doi: 10.1007/s11136-013-0597-0. [DOI] [PubMed] [Google Scholar]
- 15.Pincus T, Summey JA, Soraci SA, Jr, Wallston KA, Hummon NP. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum. 1983;26:1346–1353. doi: 10.1002/art.1780261107. [DOI] [PubMed] [Google Scholar]
- 16.Antero DC, Parra AG, Miyazaki FH, Gehlen M, Skare TL. Secondary Sjogren’s syndrome and disease activity of rheumatoid arthritis. Rev Assoc Med Bras (1992) 2011;57:319–322. doi: 10.1590/S0104-42302011000300015. [DOI] [PubMed] [Google Scholar]
- 17.Haga HJ, Naderi Y, Moreno AM, Peen E. A study of the prevalence of sicca symptoms and secondary Sjogren’s syndrome in patients with rheumatoid arthritis, and its association to disease activity and treatment profile. Int J Rheum Dis. 2012;15:284–288. doi: 10.1111/j.1756-185X.2012.01717.x. [DOI] [PubMed] [Google Scholar]
- 18.Santosh K, Dhir V, Singh S, Sood A, Gupta A, Sharma A, Sharma S. Prevalence of secondary Sjogren’s syndrome in Indian patients with rheumatoid arthritis: a single-center study. Int J Rheum Dis. 2017;20:870–874. doi: 10.1111/1756-185X.13017. [DOI] [PubMed] [Google Scholar]
- 19.Kauppi M, Pukkala E, Isomaki H. Elevated incidence of hematologic malignancies in patients with Sjogren’s syndrome compared with patients with rheumatoid arthritis (Finland) Cancer Causes Control. 1997;8:201–204. doi: 10.1023/A:1018472213872. [DOI] [PubMed] [Google Scholar]
- 20.Curtis JR, Chen L, Bharat A, Delzell E, Greenberg JD, Harrold L, Kremer J, Setoguchi S, Solomon DH, Xie F, Yun H. Linkage of a de-identified United States rheumatoid arthritis registry with administrative data to facilitate comparative effectiveness research. Arthritis Care Res. 2014;66:1790–1798. doi: 10.1002/acr.22377. [DOI] [PMC free article] [PubMed] [Google Scholar]
More Information
- Posts not found
